Product Code: GVR-2-68038-277-8
Large And Small-scale Bioprocessing Market Summary
The global large and small-scale bioprocessing market size was estimated at USD 80.5 billion in 2024 and is expected to reach USD 228.7 billion by 2033, growing at a CAGR of 11.86% from 2025 to 2033. This substantial growth is primarily driven by the increasing global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.
Biopharmaceutical companies invest significantly in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, which help accelerate development timelines and reduce production costs.
Global Large And Small-Scale Bioprocessing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global large and small-scale bioprocessing market on the basis of scale, workflow, product, application, use type, mode, and region:
- Scale Outlook (Revenue, USD Million, 2021 - 2033)
- Industrial Scale (Over 50,000 Litres)
- Small Scale (Less Than 50,000 Litres)
- Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Downstream Processing
- Fermentation
- Upstream Processing
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Bioreactors/Fermenters
- Cell Culture Products
- Filtration Assemblies
- Bioreactors Accessories
- Bags & Containers
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceuticals
- Speciality Industrial Chemicals
- Environmental Aids
- Use Type Outlook (Revenue, USD Million, 2021 - 2033)
- Multi-Use
- Single-Use
- Mode Outlook (Revenue, USD Million, 2021 - 2033)
- In-house
- Outsourced
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Scale
- 1.2.2. Workflow
- 1.2.3. Product
- 1.2.4. Application
- 1.2.5. Mode
- 1.2.6. Use Type
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Large and Small-Scale Bioprocessing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing implementation of single-use technology (SUT) for bioproduction
- 3.2.1.2. Rising demand for biologics
- 3.2.2. Market restraint analysis
- 3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
- 3.2.2.2. Complexity and regulatory hurdles
- 3.3. Large and small-scale bioprocessing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
Chapter 4. Large and Small-Scale Bioprocessing Market: Scale Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Large and Small-Scale Bioprocessing Market Scale Movement Analysis
- 4.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
- 4.4. Industrial Scale (Over 50,000 Litre)
- 4.4.1. Industrial Scale (Over 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.5. Small Scale (Less Than 50,000 Litre)
- 4.5.1. Small Scale (Less Than 50,000 Litre) market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Large and Small-Scale Bioprocessing Market: Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Large and Small-Scale Bioprocessing Market Product Movement Analysis
- 5.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 5.4. Bioreactors/Fermenters
- 5.4.1. Bioreactors/Fermenters market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.5. Cell Culture Products
- 5.5.1. Cell Culture Products market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.6. Bioreactors Accessories
- 5.6.1. Bioreactors Accessories market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.7. Filtration Assemblies
- 5.7.1. Filtration Assemblies market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.8. Bags & Containers
- 5.8.1. Bags & Containers market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Large and Small-Scale Bioprocessing Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Large and Small-Scale Bioprocessing Market Application Movement Analysis
- 6.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Biopharmaceuticals
- 6.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.5. Speciality Industrial Chemicals
- 6.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.6. Environmental Aids
- 6.6.1. Environmental Aids market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Large and Small-Scale Bioprocessing Market: Use Type Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Large and Small-Scale Bioprocessing Market Use Type Movement Analysis
- 7.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Use Type, 2021 to 2033 (USD Million)
- 7.4. Multi-Use
- 7.4.1. . Multi-Use market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5. . Single-Use
- 7.5.1. Single-Use market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Large and Small-Scale Bioprocessing Market: Mode Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Global Large and Small-Scale Bioprocessing Market Mode Movement Analysis
- 8.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
- 8.4. . Biopharmaceuticals
- 8.4.1. Biopharmaceuticals market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.5. Speciality Industrial Chemicals
- 8.5.1. Speciality Industrial Chemicals market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.6. . In-House
- 8.6.1. In-House market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.7. . Outsourced
- 8.7.1. Outsourced market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. Large and Small-Scale Bioprocessing Market: Workflow Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Global Large and Small-Scale Bioprocessing Market Workflow Movement Analysis
- 9.3. Global Large and Small-Scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
- 9.4. Downstream Processing
- 9.4.1. Downstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5. Fermentation
- 9.5.1. Fermentation market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.6. Upstream Processing
- 9.6.1. Upstream Processing market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 10. Large and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis
- 10.1. Regional Market Share Analysis, 2024 & 2033
- 10.2. Regional Market Dashboard
- 10.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 10.4. North America
- 10.4.1. U.S.
- 10.4.1.1. Key country dynamics
- 10.4.1.2. Regulatory Framework
- 10.4.1.3. Competitive scenario
- 10.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.4.2. Canada
- 10.4.2.1. Key country dynamics
- 10.4.2.2. Regulatory Framework
- 10.4.2.3. Competitive scenario
- 10.4.3. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.4.4. Mexico
- 10.4.4.1. Key country dynamics
- 10.4.4.2. Competitive scenario
- 10.4.4.3. Regulatory Framework
- 10.4.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5. Europe
- 10.5.1. UK
- 10.5.1.1. Key country dynamics
- 10.5.1.2. Competitive scenario
- 10.5.1.3. Regulatory Framework
- 10.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.2. Germany
- 10.5.2.1. Key country dynamics
- 10.5.2.2. Competitive scenario
- 10.5.2.3. Regulatory Framework
- 10.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.3. France
- 10.5.3.1. Key country dynamics
- 10.5.3.2. Competitive scenario
- 10.5.3.3. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.4. Italy
- 10.5.4.1. Key country dynamics
- 10.5.4.2. Competitive scenario
- 10.5.4.3. Regulatory Framework
- 10.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.5. Spain
- 10.5.5.1. Key country dynamics
- 10.5.5.2. Competitive scenario
- 10.5.5.3. Regulatory Framework
- 10.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.6. Norway
- 10.5.6.1. Key country dynamics
- 10.5.6.2. Competitive scenario
- 10.5.6.3. Regulatory Framework
- 10.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.7. Sweden
- 10.5.7.1. Key country dynamics
- 10.5.7.2. Competitive scenario
- 10.5.7.3. Regulatory Framework
- 10.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.5.8. Denmark
- 10.5.8.1. Key country dynamics
- 10.5.8.2. Competitive scenario
- 10.5.8.3. Regulatory Framework
- 10.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6. Asia Pacific
- 10.6.1. Japan
- 10.6.1.1. Key country dynamics
- 10.6.1.2. Competitive scenario
- 10.6.1.3. Regulatory Framework
- 10.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.2. China
- 10.6.2.1. Key country dynamics
- 10.6.2.2. Competitive scenario
- 10.6.2.3. Regulatory Framework
- 10.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.3. India
- 10.6.3.1. Key country dynamics
- 10.6.3.2. Competitive scenario
- 10.6.3.3. Regulatory Framework
- 10.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.4. Australia
- 10.6.4.1. Key country dynamics
- 10.6.4.2. Competitive scenario
- 10.6.4.3. Regulatory Framework
- 10.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.5. South Korea
- 10.6.5.1. Key country dynamics
- 10.6.5.2. Competitive scenario
- 10.6.5.3. Regulatory Framework
- 10.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.6.6. Thailand
- 10.6.6.1. Key country dynamics
- 10.6.6.2. Competitive scenario
- 10.6.6.3. Regulatory Framework
- 10.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.7. Latin America
- 10.7.1. Brazil
- 10.7.1.1. Key country dynamics
- 10.7.1.2. Competitive scenario
- 10.7.1.3. Regulatory Framework
- 10.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.7.2. Argentina
- 10.7.2.1. Key country dynamics
- 10.7.2.2. Competitive scenario
- 10.7.2.3. Regulatory Framework
- 10.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8. MEA
- 10.8.1. South Africa
- 10.8.1.1. Key country dynamics
- 10.8.1.2. Competitive scenario
- 10.8.1.3. Regulatory Framework
- 10.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.2. Saudi Arabia
- 10.8.2.1. Key country dynamics
- 10.8.2.2. Competitive scenario
- 10.8.2.3. Regulatory Framework
- 10.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.3. UAE
- 10.8.3.1. Key country dynamics
- 10.8.3.2. Competitive scenario
- 10.8.3.3. Regulatory Framework
- 10.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 10.8.4. Kuwait
- 10.8.4.1. Key country dynamics
- 10.8.4.2. Competitive scenario
- 10.8.4.3. Regulatory Framework
- 10.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 11. Competitive Landscape
- 11.1. Company/Competition Categorization
- 11.2. Strategy Mapping
- 11.3. Company Market Position Analysis, 2024
- 11.4. Company Profiles/Listing
- 11.4.1. Merck KGaA
- 11.4.1.1. Company overview
- 11.4.1.2. Financial performance
- 11.4.1.3. Product benchmarking
- 11.4.1.4. Strategic initiatives
- 11.4.2. Thermo Fisher Scientific, Inc.
- 11.4.2.1. Company overview
- 11.4.2.2. Financial performance
- 11.4.2.3. Product benchmarking
- 11.4.2.4. Strategic initiatives
- 11.4.3. Danaher (Cytiva)
- 11.4.3.1. Company overview
- 11.4.3.2. Financial performance
- 11.4.3.3. Product benchmarking
- 11.4.3.4. Strategic initiatives
- 11.4.4. Corning Inc.
- 11.4.4.1. Company overview
- 11.4.4.2. Financial performance
- 11.4.4.3. Product benchmarking
- 11.4.4.4. Strategic initiatives
- 11.4.5. Sartorius AG
- 11.4.5.1. Company overview
- 11.4.5.2. Financial performance
- 11.4.5.3. Product benchmarking
- 11.4.5.4. Strategic initiatives
- 11.4.6. CESCO BIOENGINEERING CO., LTD
- 11.4.6.1. Company overview
- 11.4.6.2. Financial performance
- 11.4.6.3. Product benchmarking
- 11.4.6.4. Strategic initiatives
- 11.4.7. Bio-Process Group
- 11.4.7.1. Company overview
- 11.4.7.2. Financial performance
- 11.4.7.3. Product benchmarking
- 11.4.7.4. Strategic initiatives
- 11.4.8. BPC Instruments AB
- 11.4.8.1. Company overview
- 11.4.8.2. Financial performance
- 11.4.8.3. Product benchmarking
- 11.4.8.4. Strategic initiatives
- 11.4.9. Eppendorf AG
- 11.4.9.1. Company overview
- 11.4.9.2. Financial performance
- 11.4.9.3. Product benchmarking
- 11.4.9.4. Strategic initiatives
- 11.4.10. Getinge AB
- 11.4.10.1. Company overview
- 11.4.10.2. Financial performance
- 11.4.10.3. Product benchmarking
- 11.4.10.4. Strategic initiatives
- 11.4.11. Lonza
- 11.4.11.1. Company overview
- 11.4.11.2. Financial performance
- 11.4.11.3. Product benchmarking
- 11.4.11.4. Strategic initiatives
- 11.4.12. PBS Biotech, Inc
- 11.4.12.1. Company overview
- 11.4.12.2. Financial performance
- 11.4.12.3. Product benchmarking
- 11.4.12.4. Strategic initiatives
- 11.4.13. Bio-Synthesis, Inc.
- 11.4.13.1. Company overview
- 11.4.13.2. Financial performance
- 11.4.13.3. Product benchmarking
- 11.4.13.4. Strategic initiatives
- 11.4.14. Meissner Filtration Products, Inc.
- 11.4.14.1. Company overview
- 11.4.14.2. Financial performance
- 11.4.14.3. Product benchmarking
- 11.4.14.4. Strategic initiatives
- 11.4.15. Entegris
- 11.4.15.1. Company overview
- 11.4.15.2. Financial performance
- 11.4.15.3. Product benchmarking
- 11.4.15.4. Strategic initiatives
- 11.4.16. KUHNER AG
- 11.4.16.1. Company overview
- 11.4.16.2. Financial performance
- 11.4.16.3. Product benchmarking
- 11.4.16.4. Strategic initiatives
- 11.4.17. Saint-Gobain
- 11.4.17.1. Company overview
- 11.4.17.2. Financial performance
- 11.4.17.3. Product benchmarking
- 11.4.17.4. Strategic initiatives
- 11.4.18. ExcellGene SA
- 11.4.18.1. Company overview
- 11.4.18.2. Financial performance
- 11.4.18.3. Product benchmarking
- 11.4.18.4. Strategic initiatives
- 11.4.19. Repligen Corporation
- 11.4.19.1. Company overview
- 11.4.19.2. Financial performance
- 11.4.19.3. Product benchmarking
- 11.4.19.4. Strategic initiatives
- 11.4.20. Avantor, Inc
- 11.4.20.1. Company overview
- 11.4.20.2. Financial performance
- 11.4.20.3. Product benchmarking
- 11.4.20.4. Strategic initiatives
- 11.4.21. CerCell A/S
- 11.4.21.1. Company overview
- 11.4.21.2. Financial performance
- 11.4.21.3. Product benchmarking
- 11.4.21.4. Strategic initiatives
- 11.4.22. Univercells Technologies
- 11.4.22.1. Company overview
- 11.4.22.2. Financial performance
- 11.4.22.3. Product benchmarking
- 11.4.22.4. Strategic initiatives
- 11.4.23. Distek, Inc.
- 11.4.23.1. Company overview
- 11.4.23.2. Financial performance
- 11.4.23.3. Product benchmarking
- 11.4.23.4. Strategic initiatives
- 11.4.24. F. Hoffmann-La Roche Ltd
- 11.4.24.1. Company overview
- 11.4.24.2. Financial performance
- 11.4.24.3. Product benchmarking
- 11.4.24.4. Strategic initiatives